PR01.04 A Novel Immunomodulatory Signature Improves Prediction of Response to Immunotherapy Compared to PD-L1 IHC in NSCLC Patients.
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology January 2021 16(1) Supplement:S41-S42 - Subject
- Language
- ISSN
- 1556-0864